Bard Financial Services Inc. Has $3.87 Million Position in Roche Holding AG (OTCMKTS:RHHBY)

Bard Financial Services Inc. raised its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 37.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 110,850 shares of the company's stock after purchasing an additional 30,350 shares during the quarter. Bard Financial Services Inc.'s holdings in Roche were worth $3,866,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RHHBY. Rhumbline Advisers increased its stake in shares of Roche by 0.9% during the second quarter. Rhumbline Advisers now owns 103,985 shares of the company's stock worth $3,605,000 after purchasing an additional 904 shares during the period. Altrius Capital Management Inc increased its position in Roche by 6.0% during the 2nd quarter. Altrius Capital Management Inc now owns 224,804 shares of the company's stock worth $7,794,000 after buying an additional 12,646 shares during the period. Norman Fields Gottscho Capital Management LLC lifted its holdings in shares of Roche by 5.5% during the third quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company's stock worth $1,039,000 after buying an additional 1,350 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Roche by 57.7% in the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company's stock valued at $317,000 after acquiring an additional 2,906 shares during the period. Finally, Diversified Trust Co grew its stake in shares of Roche by 6.4% in the third quarter. Diversified Trust Co now owns 59,742 shares of the company's stock valued at $2,396,000 after acquiring an additional 3,613 shares in the last quarter.

Roche Trading Up 1.0 %

Shares of RHHBY traded up $0.34 during mid-day trading on Monday, reaching $35.52. The company had a trading volume of 2,647,615 shares, compared to its average volume of 1,580,905. The company's 50 day simple moving average is $36.18 and its 200 day simple moving average is $37.97. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $42.43.

Wall Street Analyst Weigh In

RHHBY has been the subject of a number of recent analyst reports. Bank of America upgraded Roche from a "neutral" rating to a "buy" rating in a research report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a "hold" rating to a "sell" rating in a research note on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold".

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.